+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Antipsychotic Drugs Market Research Report by Class (First Generation, Second Generation, and Third generation), by Application (Bipolar disorders, Dementia, Schizophrenia, and Unipolar Depression) - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • ID: 5305498
  • Report
  • March 2021
  • Region: Global
  • 189 pages
  • 360iResearch™
UP TO OFF
until Jun 30th 2021
The Global Antipsychotic Drugs Market to Grow USD 10,835.86 Million by 2025, at a CAGR of 6.98%

FEATURED COMPANIES

  • Alkermes PLC
  • AMBOSS GmbH
  • Daiichi Sankyo Co. Ltd.
  • F.Hoffmann-La Roche AG
  • H. Lundbeck A/S
  • Luye Pharma Group
Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Antipsychotic Drugs Market is expected to grow from USD 7,729.88 Million in 2020 to USD 10,835.86 Million by the end of 2025.
2. The Global Antipsychotic Drugs Market is expected to grow from EUR 6,777.70 Million in 2020 to EUR 9,501.08 Million by the end of 2025.
3. The Global Antipsychotic Drugs Market is expected to grow from GBP 6,025.39 Million in 2020 to GBP 8,446.48 Million by the end of 2025.
4. The Global Antipsychotic Drugs Market is expected to grow from JPY 824,974.55 Million in 2020 to JPY 1,156,460.84 Million by the end of 2025.
5. The Global Antipsychotic Drugs Market is expected to grow from AUD 11,224.82 Million in 2020 to AUD 15,735.10 Million by the end of 2025.

Market Segmentation & Coverage:

This research report categorizes the Antipsychotic Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Class, the Antipsychotic Drugs Market is examined across First Generation, Second Generation, and Third generation. The First Generation further studied across Haldo and Navane. The Second Generation further studied across Geodon, Invega, Latuda, Risperdal, Seroquel, and Zyprexa. The Third generation further studied across Abilify.

Based on Application, the Antipsychotic Drugs Market is examined across Bipolar disorders, Dementia, Schizophrenia, and Unipolar Depression.

Based on Geography, the Antipsychotic Drugs Market is examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Antipsychotic Drugs Market including Alkermes PLC, Allergan PLC, AMBOSS GmbH, AstraZeneca PLC, Bristol-Myers Squibb Company, Daiichi Sankyo Co. Ltd., Dr. Reddy's Laboratories, Ltd., Eli Lilly & Co., F.Hoffmann-La Roche AG, Flagship Biotech International Pvt. Ltd, GlaxoSmithKline PLC, H. Lundbeck A/S, Karger AG, Luye Pharma Group, Merck & Co., Inc., Novartis AG, Otsuka Pharmaceutical Co. Ltd., Pfizer, Inc., Questex LLC, Sumitomo Dainippon Pharma Co., Ltd., Teva Pharmaceutical Industries, Ltd., The Medicines Co., and Vanda Pharmaceuticals Inc..

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Antipsychotic Drugs Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Antipsychotic Drugs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Antipsychotic Drugs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Antipsychotic Drugs Market?
4. What is the competitive strategic window for opportunities in the Global Antipsychotic Drugs Market?
5. What are the technology trends and regulatory frameworks in the Global Antipsychotic Drugs Market?
6. What are the modes and strategic moves considered suitable for entering the Global Antipsychotic Drugs Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Alkermes PLC
  • AMBOSS GmbH
  • Daiichi Sankyo Co. Ltd.
  • F.Hoffmann-La Roche AG
  • H. Lundbeck A/S
  • Luye Pharma Group
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Application Outlook
3.4. Class Outlook
3.5. Geography Outlook
3.6. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of psychosis and associated diseases
5.1.2. Restraints
5.1.2.1. Patent expiry of established brands
5.1.3. Opportunities
5.1.3.1. Increasing prevalence of psychosis and associated diseases
5.1.3.2. Enhancement in healthcare facilities coupled with government efforts to improve healthcare sector
5.1.4. Challenges
5.1.4.1. Negative impact on the patients such as insomnia, blurred vision, and dry mouth
5.1.4.2. Stringent regulatory framework and compliance
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Global Antipsychotic Drugs Market, By Class
6.1. Introduction
6.2. First Generation
6.2.1. Haldo
6.2.2. Navane
6.3. Second Generation
6.3.1. Geodon
6.3.2. Invega
6.3.3. Latuda
6.3.4. Risperdal
6.3.5. Seroquel
6.3.6. Zyprexa
6.4. Third generation
6.4.1. Abilify

7. Global Antipsychotic Drugs Market, By Application
7.1. Introduction
7.2. Bipolar disorders
7.3. Dementia
7.4. Schizophrenia
7.5. Unipolar Depression

8. Americas Antipsychotic Drugs Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Antipsychotic Drugs Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. South Korea
9.10. Thailand

10. Europe, Middle East & Africa Antipsychotic Drugs Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitor SWOT Analysis
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Alkermes PLC
12.2. Allergan PLC
12.3. AMBOSS GmbH
12.4. AstraZeneca PLC
12.5. Bristol-Myers Squibb Company
12.6. Daiichi Sankyo Co. Ltd.
12.7. Dr. Reddy's Laboratories, Ltd.
12.8. Eli Lilly & Co.
12.9. F.Hoffmann-La Roche AG
12.10. Flagship Biotech International Pvt. Ltd
12.11. GlaxoSmithKline PLC
12.12. H. Lundbeck A/S
12.13. Karger AG
12.14. Luye Pharma Group
12.15. Merck & Co., Inc.
12.16. Novartis AG
12.17. Otsuka Pharmaceutical Co. Ltd.
12.18. Pfizer, Inc.
12.19. Questex LLC
12.20. Sumitomo Dainippon Pharma Co., Ltd.
12.21. Teva Pharmaceutical Industries, Ltd.
12.22. The Medicines Co.
12.23. Vanda Pharmaceuticals Inc.

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures
Figure 1. Global Antipsychotic Drugs Market: Research Process
Figure 2. Global Antipsychotic Drugs Market: Research Execution
Figure 3. Global Antipsychotic Drugs Market Size, 2020 Vs 2025 (USD Million)
Figure 4. Global Antipsychotic Drugs Market Size, by Application, 2020 (USD Million)
Figure 5. Global Antipsychotic Drugs Market Size, by Class, 2020 (USD Million)
Figure 6. Global Antipsychotic Drugs Market Size, by Geography, 2020 (USD Million)
Figure 7. Global Antipsychotic Drugs Market Size, 2018-2025 (USD Million)
Figure 8. Global Antipsychotic Drugs Market Size, by Geography, 2020 Vs 2025 (%)
Figure 9. Global Antipsychotic Drugs Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 10. Competitive Strategic Window for Global Antipsychotic Drugs Market Size, by Geography, 2025
Figure 11. Global Antipsychotic Drugs Market: Market Dynamics
Figure 12. Global Antipsychotic Drugs Market: Porters Five Forces Analysis
Figure 13. Global Antipsychotic Drugs Market Size, by Class, 2020 Vs 2025 (%)
Figure 14. Global Antipsychotic Drugs Market Size, by Class, 2020 Vs 2025 (USD Million)
Figure 15. Competitive Strategic Window for Global Antipsychotic Drugs Market Size, by Class, 2025
Figure 16. Global Antipsychotic Drugs Market Size, by First Generation, 2020 Vs 2025 (USD Million)
Figure 17. Global Antipsychotic Drugs Market Size, by Haldo, 2020 Vs 2025 (USD Million)
Figure 18. Global Antipsychotic Drugs Market Size, by Navane, 2020 Vs 2025 (USD Million)
Figure 19. Global Antipsychotic Drugs Market Size, by Second Generation, 2020 Vs 2025 (USD Million)
Figure 20. Global Antipsychotic Drugs Market Size, by Geodon, 2020 Vs 2025 (USD Million)
Figure 21. Global Antipsychotic Drugs Market Size, by Invega, 2020 Vs 2025 (USD Million)
Figure 22. Global Antipsychotic Drugs Market Size, by Latuda, 2020 Vs 2025 (USD Million)
Figure 23. Global Antipsychotic Drugs Market Size, by Risperdal, 2020 Vs 2025 (USD Million)
Figure 24. Global Antipsychotic Drugs Market Size, by Seroquel, 2020 Vs 2025 (USD Million)
Figure 25. Global Antipsychotic Drugs Market Size, by Zyprexa, 2020 Vs 2025 (USD Million)
Figure 26. Global Antipsychotic Drugs Market Size, by Third Generation, 2020 Vs 2025 (USD Million)
Figure 27. Global Antipsychotic Drugs Market Size, by Abilify, 2020 Vs 2025 (USD Million)
Figure 28. Global Antipsychotic Drugs Market Size, by Application, 2020 Vs 2025 (%)
Figure 29. Global Antipsychotic Drugs Market Size, by Application, 2020 Vs 2025 (USD Million)
Figure 30. Competitive Strategic Window for Global Antipsychotic Drugs Market Size, by Application, 2025
Figure 31. Global Antipsychotic Drugs Market Size, by Bipolar Disorders, 2020 Vs 2025 (USD Million)
Figure 32. Global Antipsychotic Drugs Market Size, by Dementia, 2020 Vs 2025 (USD Million)
Figure 33. Global Antipsychotic Drugs Market Size, by Schizophrenia, 2020 Vs 2025 (USD Million)
Figure 34. Global Antipsychotic Drugs Market Size, by Unipolar Depression, 2020 Vs 2025 (USD Million)
Figure 35. Americas Antipsychotic Drugs Market Size, by Geography, 2020 Vs 2025 (%)
Figure 36. Americas Antipsychotic Drugs Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 37. Competitive Strategic Window for Americas Antipsychotic Drugs Market Size, by Geography, 2025
Figure 38. Argentina Antipsychotic Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 39. Brazil Antipsychotic Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 40. Canada Antipsychotic Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 41. Mexico Antipsychotic Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 42. United States Antipsychotic Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 43. Asia-Pacific Antipsychotic Drugs Market Size, by Geography, 2020 Vs 2025 (%)
Figure 44. Asia-Pacific Antipsychotic Drugs Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 45. Competitive Strategic Window for Asia-Pacific Antipsychotic Drugs Market Size, by Geography, 2025
Figure 46. Australia Antipsychotic Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 47. China Antipsychotic Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 48. India Antipsychotic Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 49. Indonesia Antipsychotic Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 50. Japan Antipsychotic Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 51. Malaysia Antipsychotic Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 52. Philippines Antipsychotic Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 53. South Korea Antipsychotic Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 54. Thailand Antipsychotic Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 55. Europe, Middle East & Africa Antipsychotic Drugs Market Size, by Geography, 2020 Vs 2025 (%)
Figure 56. Europe, Middle East & Africa Antipsychotic Drugs Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 57. Competitive Strategic Window for Europe, Middle East & Africa Antipsychotic Drugs Market Size, by Geography, 2025
Figure 58. France Antipsychotic Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 59. Germany Antipsychotic Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 60. Italy Antipsychotic Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 61. Netherlands Antipsychotic Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 62. Qatar Antipsychotic Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 63. Russia Antipsychotic Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 64. Saudi Arabia Antipsychotic Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 65. South Africa Antipsychotic Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 66. Spain Antipsychotic Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 67. United Arab Emirates Antipsychotic Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 68. United Kingdom Antipsychotic Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 69. Global Antipsychotic Drugs Market: Fpnv Positioning Matrix
Figure 70. Global Antipsychotic Drugs Market: Market Share Analysis
Figure 71. Global Antipsychotic Drugs Market: Competitor SWOT Analysis
Figure 72. Competitive Scenario Analysis in Global Antipsychotic Drugs Market, by Type

List of Tables
Table 1. Currency Conversion Rates
Table 2. Global Antipsychotic Drugs Market Size, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 3. Global Antipsychotic Drugs Market Size, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 4. Global Antipsychotic Drugs Market Size, by Class, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 5. Global Antipsychotic Drugs Market Size, by First Generation, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 6. Global Antipsychotic Drugs Market Size, by Haldo, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 7. Global Antipsychotic Drugs Market Size, by Navane, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 8. Global Antipsychotic Drugs Market Size, by Second Generation, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 9. Global Antipsychotic Drugs Market Size, by Geodon, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 10. Global Antipsychotic Drugs Market Size, by Invega, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 11. Global Antipsychotic Drugs Market Size, by Latuda, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 12. Global Antipsychotic Drugs Market Size, by Risperdal, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 13. Global Antipsychotic Drugs Market Size, by Seroquel, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 14. Global Antipsychotic Drugs Market Size, by Zyprexa, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 15. Global Antipsychotic Drugs Market Size, by Third Generation, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 16. Global Antipsychotic Drugs Market Size, by Abilify, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 17. Global Antipsychotic Drugs Market Size, by Application, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 18. Global Antipsychotic Drugs Market Size, by Bipolar Disorders, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 19. Global Antipsychotic Drugs Market Size, by Dementia, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 20. Global Antipsychotic Drugs Market Size, by Schizophrenia, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 21. Global Antipsychotic Drugs Market Size, by Unipolar Depression, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 22. Americas Antipsychotic Drugs Market Size, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 23. Americas Antipsychotic Drugs Market Size, by Application, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 24. Americas Antipsychotic Drugs Market Size, by Class, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 25. Argentina Antipsychotic Drugs Market Size, by Application, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 26. Argentina Antipsychotic Drugs Market Size, by Class, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 27. Brazil Antipsychotic Drugs Market Size, by Application, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 28. Brazil Antipsychotic Drugs Market Size, by Class, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 29. Canada Antipsychotic Drugs Market Size, by Application, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 30. Canada Antipsychotic Drugs Market Size, by Class, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 31. Mexico Antipsychotic Drugs Market Size, by Application, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 32. Mexico Antipsychotic Drugs Market Size, by Class, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 33. United States Antipsychotic Drugs Market Size, by Application, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 34. United States Antipsychotic Drugs Market Size, by Class, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 35. Asia-Pacific Antipsychotic Drugs Market Size, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 36. Asia-Pacific Antipsychotic Drugs Market Size, by Application, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 37. Asia-Pacific Antipsychotic Drugs Market Size, by Class, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 38. Australia Antipsychotic Drugs Market Size, by Application, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 39. Australia Antipsychotic Drugs Market Size, by Class, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 40. China Antipsychotic Drugs Market Size, by Application, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 41. China Antipsychotic Drugs Market Size, by Class, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 42. India Antipsychotic Drugs Market Size, by Application, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 43. India Antipsychotic Drugs Market Size, by Class, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 44. Indonesia Antipsychotic Drugs Market Size, by Application, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 45. Indonesia Antipsychotic Drugs Market Size, by Class, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 46. Japan Antipsychotic Drugs Market Size, by Application, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 47. Japan Antipsychotic Drugs Market Size, by Class, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 48. Malaysia Antipsychotic Drugs Market Size, by Application, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 49. Malaysia Antipsychotic Drugs Market Size, by Class, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 50. Philippines Antipsychotic Drugs Market Size, by Application, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 51. Philippines Antipsychotic Drugs Market Size, by Class, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 52. South Korea Antipsychotic Drugs Market Size, by Application, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 53. South Korea Antipsychotic Drugs Market Size, by Class, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 54. Thailand Antipsychotic Drugs Market Size, by Application, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 55. Thailand Antipsychotic Drugs Market Size, by Class, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 56. Europe, Middle East & Africa Antipsychotic Drugs Market Size, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 57. Europe, Middle East & Africa Antipsychotic Drugs Market Size, by Application, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 58. Europe, Middle East & Africa Antipsychotic Drugs Market Size, by Class, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 59. France Antipsychotic Drugs Market Size, by Application, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 60. France Antipsychotic Drugs Market Size, by Class, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 61. Germany Antipsychotic Drugs Market Size, by Application, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 62. Germany Antipsychotic Drugs Market Size, by Class, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 63. Italy Antipsychotic Drugs Market Size, by Application, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 64. Italy Antipsychotic Drugs Market Size, by Class, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 65. Netherlands Antipsychotic Drugs Market Size, by Application, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 66. Netherlands Antipsychotic Drugs Market Size, by Class, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 67. Qatar Antipsychotic Drugs Market Size, by Application, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 68. Qatar Antipsychotic Drugs Market Size, by Class, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 69. Russia Antipsychotic Drugs Market Size, by Application, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 70. Russia Antipsychotic Drugs Market Size, by Class, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 71. Saudi Arabia Antipsychotic Drugs Market Size, by Application, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 72. Saudi Arabia Antipsychotic Drugs Market Size, by Class, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 73. South Africa Antipsychotic Drugs Market Size, by Application, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 74. South Africa Antipsychotic Drugs Market Size, by Class, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 75. Spain Antipsychotic Drugs Market Size, by Application, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 76. Spain Antipsychotic Drugs Market Size, by Class, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 77. United Arab Emirates Antipsychotic Drugs Market Size, by Application, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 78. United Arab Emirates Antipsychotic Drugs Market Size, by Class, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 79. United Kingdom Antipsychotic Drugs Market Size, by Application, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 80. United Kingdom Antipsychotic Drugs Market Size, by Class, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 81. Global Antipsychotic Drugs Market: Scores
Table 82. Global Antipsychotic Drugs Market: Business Strategy
Table 83. Global Antipsychotic Drugs Market: Product Satisfaction
Table 84. Global Antipsychotic Drugs Market: Ranking
Table 85. Global Antipsychotic Drugs Market: Merger & Acquisition
Table 86. Global Antipsychotic Drugs Market: Agreement, Collaboration, & Partnership
Table 87. Global Antipsychotic Drugs Market: New Product Launch & Enhancement
Table 88. Global Antipsychotic Drugs Market: Investment & Funding
Table 89. Global Antipsychotic Drugs Market: Award, Recognition, & Expansion
Table 90. Global Antipsychotic Drugs Market: License & Pricing
Note: Product cover images may vary from those shown
  • Alkermes PLC
  • Allergan PLC
  • AMBOSS GmbH
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Daiichi Sankyo Co. Ltd.
  • Dr. Reddy's Laboratories, Ltd.
  • Eli Lilly & Co.
  • F.Hoffmann-La Roche AG
  • Flagship Biotech International Pvt. Ltd
  • GlaxoSmithKline PLC
  • H. Lundbeck A/S
  • Karger AG
  • Luye Pharma Group
  • Merck & Co., Inc.
  • Novartis AG
  • Otsuka Pharmaceutical Co. Ltd.
  • Pfizer, Inc.
  • Questex LLC
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Teva Pharmaceutical Industries, Ltd.
  • The Medicines Co.
  • Vanda Pharmaceuticals Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll